184 related articles for article (PubMed ID: 1898640)
21. Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 Study.
Ip JE; Coutu B; Bennett MT; Pandey AS; Stambler BS; Sager P; Chen M; Shardonofsky S; Plat F; Camm AJ
J Am Heart Assoc; 2023 Oct; 12(19):e028227. PubMed ID: 37753718
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
Alboni P; Tomasi C; Menozzi C; Bottoni N; Paparella N; Fucà G; Brignole M; Cappato R
J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
24. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
Ballo P; Bernabò D; Faraguti SA
Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
[TBL] [Abstract][Full Text] [Related]
25. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
Pritchett EL; McCarthy EA; Wilkinson WE
Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
Hoff PI; Tronstad A; Oie B; Ohm OJ
Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
[TBL] [Abstract][Full Text] [Related]
27. Treatment of paroxysmal supraventricular tachycardia with oral diltiazem.
Clair WK; Wilkinson WE; McCarthy EA; Pritchett EL
Clin Pharmacol Ther; 1992 May; 51(5):562-5. PubMed ID: 1587069
[TBL] [Abstract][Full Text] [Related]
28. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
Page RL; Pritchett EL; Connolly S; Wilkinson WE;
J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
[TBL] [Abstract][Full Text] [Related]
29. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
Anderson JL
Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
31. Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia.
Go AS; Hlatky MA; Liu TI; Fan D; Garcia EA; Sung SH; Solomon MD
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982228
[TBL] [Abstract][Full Text] [Related]
32. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
34. Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial.
Stambler BS; Ip JE
Cardiol Ther; 2023 Dec; 12(4):545-555. PubMed ID: 37950144
[TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
Neuss H; Schlepper M
Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
[TBL] [Abstract][Full Text] [Related]
36. Long term use of flecainide in patients with supraventricular tachycardia.
Neuss H
Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
[TBL] [Abstract][Full Text] [Related]
37. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol.
Yeh SJ; Lin FC; Chou YY; Hung JS; Wu D
Circulation; 1985 Jan; 71(1):104-9. PubMed ID: 3964710
[TBL] [Abstract][Full Text] [Related]
38. Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia.
Stambler BS; Plat F; Sager PT; Lubkov V; Shardonofsky S; Wight D; Chen M; Camm AJ
Am Heart J; 2022 Nov; 253():20-29. PubMed ID: 35728658
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
[TBL] [Abstract][Full Text] [Related]
40. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
Ellenbogen KA; O'Neill G; Prystowsky EN; Camm JA; Meng L; Lieu HD; Jerling M; Shreeniwas R; Belardinelli L; Wolff AA;
Circulation; 2005 Jun; 111(24):3202-8. PubMed ID: 15956124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
